Spirig Pharma AG in Beauty and Personal Care (Switzerland)

October 2013 | 3 pages | ID: S71FDE211BAEN
Euromonitor International Ltd

Abstracts

Spirig Pharma’s strategic direction remains clearly focused on recognising customers’ needs, whilst striving to develop products and solutions with the highest standards of quality and technology. Spirig further seeks to develop outside Switzerland by expanding in international markets. In 2012 Spirig was acquired by Galderma, a joint-venture between Nestlé and L’Oréal based in Switzerland. This strategic move will enable both entities to benefit from their synergies, as well as developing a...

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Baby and Child-specific Products, Bath and Shower, Colour Cosmetics, Deodorants, Depilatories, Fragrances, Hair Care, Mass Cosmetics, Men's Grooming, Oral Care, Oral Care Excl Power Toothbrushes, Premium Cosmetics, Sets/Kits, Skin Care, Sun Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Beauty and Personal Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Spirig Pharma AG: Key Facts
Summary 2 Spirig Pharma AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Spirig Pharma AG: Competitive Position 2012